Notice

The database server is currently not answering requests properly. Some pages are still available due to caching. We are investigating the situation and will keep you updated.

Beijing Advaccine Biotechnology

China

1 June 2019 - 31 May 2020

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Beijing Advaccine Biotechnology published between 1 June 2019 - 31 May 2020 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Count Share
1 0.03

Outputs by subject (Share)

Subject Count Share
Life Sciences 1 0.03

Top articles by Altmetric score in current window

1 June 2019 - 31 May 2020

International vs. domestic collaboration by Share

  • 11.94% Domestic
  • 88.06% International

Note: Hover over the graph to view the percentage of collaboration.

Top 10 domestic collaborators by Share (1 total)

  • Beijing Advaccine Biotechnology, China
  • Domestic institution
  1. Fudan University, China (0.14)
    0.03
    0.10

Top 10 international collaborators by Share (4 total)

  • Beijing Advaccine Biotechnology, China
  • Foreign institution
  1. The Wistar Institute, United States of America (USA) (0.47)
    0.03
    0.44
  2. Inovio Pharmaceuticals, Inc.,, United States of America (USA) (0.37)
    0.03
    0.34
  3. The University of Texas at Austin (UT Austin), United States of America (USA) (0.08)
    0.03
    0.05
  4. Public Health England (PHE), United Kingdom (UK) (0.07)
    0.03
    0.03

Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.

Return to institution outputs